Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PLAU | P00749 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1405463 | 1.00 | TP53 (0.59) | TP53ALDH1A1MAPTRAB9AMEN1 | |
| SCHEMBL13638200 | 0.90 | PLAU (0.56) | TP53ALDH1A1MAPTRAB9AMEN1 | |
| SCHEMBL24212689 | 0.90 | PLAU (0.56) | TP53ALDH1A1MAPTRAB9AMEN1 | |
| SCHEMBL875358 | 0.82 | ALDH1A1 (0.52) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL12786219 | 0.82 | ALDH1A1 (0.52) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL23511155 | 0.81 | PLAU (0.48) | TP53MAPTRAB9AMEN1KMT2A | |
| SCHEMBL13278248 | 0.80 | ALDH1A1 (0.63) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL13278246 | 0.80 | ALDH1A1 (0.63) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| Azobenzene SCHEMBL15261802 | 0.79 | ALDH1A1 (0.71) | ALDH1A1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL14850545 | 0.79 | MEN1 (0.54) | TP53ALDH1A1MAPTRAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119208436-A | Photovoltaic cell preparation method and photovoltaic cell | 晶科能源(上饶)有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-9932300-B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-04-03 | — | — | US | disclosed |
| US-20170327743-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME | JNC CORP (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-11-03 | — | — | US | disclosed |
| US-9421211-B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-08-23 | — | — | US | disclosed |
| US-8304076-B2 | Particles with photochromic and light absorbing material for reimageable medium | XEROX CORPORATION (US) | 2012-11-06 | — | — | US | disclosed |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-05-10 | — | — | US | disclosed |
| US-7964271-B2 | Photochromic medium with erase-on-demand capability | XEROX CORPORATION (US) | 2011-06-21 | — | — | US | disclosed |
| EP-1591830-B1 | Reimageable medium | XEROX CORP (US) | 2011-03-09 | — | — | EP | disclosed |
| US-7709164-B2 | Solvent-less process for producing transient documents | XEROX CORPORATION (US) | 2010-05-04 | — | — | US | disclosed |
| US-20060222972-A1 | Dual-layer protected transient document | XEROX CORPORATION | 2006-10-05 | — | — | US | disclosed |
| US-20050287475-A1 | Solvent-less process for producing transient documents | XEROX CORPORATION | 2005-12-29 | — | — | US | disclosed |
| CN-1702545-A | Method for forming temporary image | XEROX CORP (US) | 2005-11-30 | — | — | CN | disclosed |
| CN-1702546-A | Method for forming temporary image | XEROX CORP (US) | 2005-11-30 | — | — | CN | disclosed |
| US-20050244743-A1 | Reimageable medium | XEROX CORPORATION. | 2005-11-03 | — | — | US | disclosed |
| US-20050244744-A1 | Method for forming temporary image | XEROX CORPORATION | 2005-11-03 | — | — | US | disclosed |
| US-20050244742-A1 | Reimageable medium with light absorbing material | XEROX CORPORATION | 2005-11-03 | — | — | US | disclosed |
| EP-1591830-A2 | Reimageable medium | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1591831-A2 | Reimageable medium with light absorbing material | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1591829-A1 | Method for forming temporary image | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | NSUN2, EIF2AK2, RNGTT | TP53 1092/4885ALDH1A1 3464/4885MAPT 1631/4885 |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | NSUN2, EIF2AK2, RNGTT | TP53 1092/4885ALDH1A1 3464/4885MAPT 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.